Cited by 110Saffron Plant Research StudiesTreatment of Major DepressionMedicinal Plant Extracts Effects

Crocus sativus L. versus citalopram in the treatment of major depressive disorder with anxious distress: a double-blind, controlled clinical trial

Open access
Ghajar, A., Neishabouri, S., Velayati, N., Jahangard, L., Matinnia, N., Haghighi, M., Ghaleiha, A., Afarideh, M. +3 more·2017·Pharmacopsychiatry

Abstract

Abstract Introduction: Saffron (Crocus sativus L.) has demonstrated antidepressant effects in clinical studies and extensive anxiolytic effects in experimental animal models. Methods: 66 patients with major depressive disorder accompanied by anxious distress were randomly assigned to receive either saffron (30 mg/day) or citalopram (40 mg/day) for 6 weeks. Hamilton Rating Scale for Depression (HAM-D) and Hamilton Rating Scale for Anxiety (HAM-A) were used to assess treatment effect during the trial. Results: 60 participants finished the study. Patients who received either saffron or citalopram showed significant improvement in scores of the Hamilton Rating Scale for Depression (P-value<0.001 in both groups) and Hamilton Rating Scale for Anxiety (P-value<0.001 in both groups). Comparison of score changes between the 2 trial arms showed no significant difference (P-value=0.984). Frequency of side effects was not significantly different between the 2 groups. Discussion: The present study indicates saffron as a potential efficacious and tolerable treatment for major depressive disorder with anxious distress.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0042-116159

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Vilazodone was more effective in 708 patients with anxious depression than in 155 patients with nonanxious depression, although the sample size of those with nonanxious depression was very small.

    “Also, vilazodone -a serotonin reuptake inhibitor and 5-hydroxytryptamine 1A receptor partial antagonist -was more effective in 708 patients with anxious depression than in 155 patients with nonanxious depression, although the sample size of those with nonanxious depression was very small [59].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Lépine J-P, Gastpar M, Mendlewicz J et al. Depression in the communi- ty: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 1997; 12: 19-29

Cited by

Sorted by citations

Authors
Ghajar, A., Neishabouri, S., Velayati, N., Jahangard, L., Matinnia, N., Haghighi, M., Ghaleiha, A., Afarideh, M., Salimi, S., Meysamie, A., & Akhondzadeh, S.
Affiliations
  • Roozbeh Hospital (IR)
  • Hamedan University of Medical Sciences (IR)
  • Baharloo Hospital (IR)
  • Tehran University of Medical Sciences (IR)
Venue
Pharmacopsychiatry
Published
2016-10-04
Volume
50
Issue
04
Pages
152-160
ISSN
  • 0176-3679 (ISSN-L)
  • 1439-0795
OpenAlex
W2528662465
Cited by
110
References
71
Citations by year
2026: 5 · 2025: 6 · 2024: 13 · 2023: 8 · 2022: 14 · 2021: 28 · 2020: 14 · 2019: 7 · 2018: 9 · 2017: 6
FWCI
3.96
Type
journal article
Language
en
Open access
Locations
  • Pharmacopsychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Saffron Plant Research Studies
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
Keywords
saffron, citalopram, major depressive disorder, anxious distress, antidepressant effects, anxiolytic effects, herbal medicine
MeSH terms
Adolescent, Adult, Aged, Antidepressive Agents, Anxiety, Depressive Disorder, Major, Major Depressive Disorder, Double-Blind Method, Female, Humans, Male, Phytotherapy, Middle Aged, Plant Extracts, Citalopram, Treatment Outcome, Crocus, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review